A new antiviral drug that induces mutations in the genetic material of influenza virus is highly effective in treating influenza infection in animals and human airway tissue and could be a groundbreaking advance in influenza therapy, according to a study by the Institute for Biomedical Sciences at Georgia State University.
The antiviral drug blocks RNA polymerase, the enzyme that plays a central role in replicating the genome of influenza virus, causing mutations in the viral genome. If enough mutations occur, the genome becomes nonfunctional and the virus cannot replicate. The findings were published online on Oct. 23 in Science Translational Medicine.
“The compound is highly efficacious against influenza,” said Dr. Richard Plemper, senior author of the study and a professor in the Institute for Biomedical Sciences. “It’s orally available, it’s broad spectrum against all influenza virus strains tested, and most important it establishes a high barrier against viral escape from inhibition.”
Influenza, caused by a contagious respiratory virus, is characterized by fever, cough, headache, muscle and joint pain, severe malaise, sore throat and sometimes gastrointestinal symptoms. Patients in higher risk groups, such as older adults and individuals with compromised immune systems, frequently require hospitalization. Each year, seasonal influenza results in 30,000 to 80,000 fatalities in the United States. The seasonal flu vaccine is only moderately effective, and licensed antivirals are compromised by rapidly emerging viral resistance to the drugs.
In the study, the new antiviral drug was tested in ferrets, the most informative animal model for human influenza disease, against various strains that include seasonal and pandemic viruses, such as the swine-origin influenza virus responsible for a 2009 pandemic. The researchers found that the antiviral drug efficiently inhibited replication of all of these strains. Virus burden dropped rapidly after treatment, and the duration of fever was significantly shorter in treated ferrets than in control animals that did not receive the drug.
“We think that the next generation of influenza antiviral drugs must not only be efficacious and safe, but also address the resistance problem,” said Dr. Mart Toots, first author of the study and a research assistant professor associated with Dr. Plemper’s lab in the Institute for Biomedical Sciences.
That is where the new drug comes in. Through a combination of conventional and ultra-deep sequencing, Toots has demonstrated in collaboration with Dr. Alex Greninger at the University of Washington that it is very challenging for the virus to find a viable way to avoid the compound.
“We have not identified specific resistance mutations yet and are confident to say that the genetic barrier against viral resistance is high,” Plemper said. “We believe that this compound has high clinical potential as a next-generation influenza drug that combines key antiviral features.”
The Latest on: Influenza
via Google News
The Latest on: Influenza
- Lake City schools warn parents of influenza outbreak among studentson January 22, 2020 at 10:12 am
Lake City Public Schools has notified parents in the district that the number of students out sick with the flu from Bluffview Elementary "now meets a threshold of an influenza-like illness outbreak." ...
- Results from Influenza Challenge Study Published in Lancet Infectious Diseaseson January 22, 2020 at 4:00 am
SOUTH SAN FRANCISCO, Calif., Jan. 22, 2020 (GLOBE NEWSWIRE) -- Vaxart, Inc. (VXRT), a clinical-stage biotechnology company developing oral recombinant vaccines administered by tablet rather than by ...
- Full influenza vaccination among children cuts hospitalization in halfon January 21, 2020 at 9:05 pm
ANN ARBOR--Fully vaccinating children reduces the risk of hospitalization associated with influenza by 54%, according to a study by researchers at the University of Michigan, the Clalit Research ...
- Fitbit data improve state-level influenza predictionson January 21, 2020 at 8:16 pm
Resting heart rates are likely spike during infectious diseases episodes, such as influenza, which is captured by wearable devices like smartwatches and fitness trackers. According to new data ...
- Influenza vaccination of children cuts hospitalization in halfon January 21, 2020 at 2:10 pm
Fully vaccinating children reduced the risk of hospitalization for complications associated with influenza by 54%, according to a new study by Ben-Gurion University of the Negev (BGU) and University ...
- Antiviral potential of 3′-sialyllactose- and 6′-sialyllactose-conjugated dendritic polymers against human and avian influenza viruseson January 21, 2020 at 3:01 am
Current treatment options for influenza virus infections in humans are limited and therefore the development of novel antivirals is of high priority. Inhibiting influenza virus attachment to host ...
- Seasonal Influenza: Epidemiology Forecast in Asia-Pacific Markets to 2028on January 20, 2020 at 4:18 pm
Seasonal Influenza: Epidemiology Forecast in Asia-Pacific Markets to 2028 NEW YORK, Jan. 20, 2020 /PRNewswire/ -- Summary Read the full report: https://www.reportlinker.com/p05839836/?utm_source=PRN ...
- Swine Influenza Vaccines Market 2019-2024 Important Factors of Revenue by Key Vendors Size, Demand, Development Strategy, Future Trendson January 20, 2020 at 8:37 am
Get comprehensive research providing detailed regional analysis and growth outlook of the Global Swine Influenza Vaccines Market in the latest research report added by Big Market Research. The report ...
- Rare early emergence of influenza B virus puts children at higher riskon January 16, 2020 at 9:22 am
The rare prevalence of the B virus -- which is more likely to impact children -- makes this an unusual and worrisome flu season.
- Oil-in-water emulsion adjuvants for pediatric influenza vaccines: a systematic review and meta-analysison January 16, 2020 at 2:21 am
Standard inactivated influenza vaccines are poorly immunogenic in immunologically naive healthy young children, who are particularly vulnerable to complications from influenza. For them, there is an ...
via Bing News